ARPIM/APMGR: The supplementation by 175 million to BaT starting from the 4th quarter is necessary
A.C. (translated by: www.silktrans.com)Ziarul BURSA #English Section / 5 august 2014
The Romanian Association of the International Drug Manufacturers (ARPIM) and the Association of Generic Medicine Manufacturers in Romania (APMGR) consider that the supplementation of the drugs' budget must be considered a priority for the Romanian patients, being necessary an extra allocation of 175 million lei to the budget quarterly approved (BaT) starting from the 4th quarter of the current year, according to a common press release of the two associations recently sent to the editorial office.